Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]

Casadei-Gardini A, Montagnani F, Casadei C, et al. Cancer Manag Res. 2019;11:3631–3642. The authors have advised that the affiliations are not correct in the published paper (page 3631). They have provided revised author and affiliations lists, as follows, and confirm that the modification...

Full description

Bibliographic Details
Main Authors: Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell'Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P
Format: Article
Language:English
Published: Dove Medical Press 2019-06-01
Series:Cancer Management and Research
Online Access:https://www.dovepress.com/corrigendum-immune-inflammation-indicators-in-anal-cancer-patient-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/corrigendum-immune-inflammation-indicators-in-anal-cancer-patient-peer-reviewed-article-CMAR

Similar Items